Impact Analysis of Covid-19
The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Medical food is consumed or enterally administered under the supervision of a physician for treatment of a disease or specific dietary management. Medical food is used for various purposes such as healthy aging, maintaining brain health, and for treating chronic medical conditions, irritable bowel syndrome, and metabolic disorders. Medical food mimics therapeutic agents used in the treatment of clinical conditions such as pain, sleep disorders, and cognitive disorders. It provides relief to pain or helps treat the condition without exhibiting any risk or side effects that are usually associated with the pharmaceutical drugs. Medical food products claiming treatment of such medical conditions or any other diseases are required to support their claim with proper scientific and clinical study results. Although medical food products do not require adherence to any particular labeling requirements, any false claims or misbranding may result in legal action by the Food, Drug & Cosmetic Act (FD & C Act). Medical food varies in forms of dosage such as powders, pills, and solutions, which allows for wider availability and reach. Advancement in nutritional therapies is a result of robust support of medical food products and their wide variety of therapeutic applications, which, to a certain extent is expected to offset prescription drugs usage.
Market Dynamics
Medical food offers various advantages over prescription drugs such as lesser side effects, lower product costs, and nutritional benefits. Leveraging the preference for convenience food formats is expected to favor long-term growth of the medical food market. Besides, personalized medicine is a developing field, wherein the patient's genetic makeup is used to guide the prevention, diagnosis, and treatment of diseases. Medical food is expected to gain a strong foothold in the personalized medicine sector. According to a report by Personalized Lifestyle Medicine Institute, in 2013, 70% of all chronic diseases were fundamentally the results of nutrition deficiencies or imbalances, in the U.S. Such nutrition-based etiologies could be directly addressed with the help of medical foods in the initial stages of diseases, preventing further loss. Thus, management of diseases by treating individual nutritional deficiencies, increases the demand for personalized medicines. The awareness regarding medical food and its benefits, among healthcare professionals and patients is critical for growth of the market.
Market Taxonomy
This report segments the global Rx medical food market on the basis of product type, therapeutic application, and distribution channel. On the basis of product type, the global Rx medical food market is segmented into pills, powders, liquid, and others (wafers, chewable, and bars). On the basis of therapeutic application, the market is segmented into pain management, sleep disorder, neurological disorder, GI disorder, pulmonary disorders, metabolic disorders, and others (fibrosis, dialysis, AIDS, etc.). On the basis of distribution channel, the market is segmented into retail pharmacies and online pharmacies. On the basis of geography, the market is segmented into North America, Europe, Asia Pacific, Latin America, Africa, and Middle East.
Key features of the study:
• This report provides in-depth analysis of Rx medical food market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017-2025), considering 2016 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
• It profiles leading players in the global Rx medical food market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
• Key companies covered as a part of this study include Abbott Laboratories, Danone, Mead Johnson & Company, LLC, Fresenius Kabi AG, Nestle, Primus Pharmaceuticals, Inc., Targeted Medical Pharma, Enzymotec ltd., AlfaSigma, and Pivotal Therapeutics.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
• The global Rx medical food market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the Rx medical food market
Detailed Segmentation:
• Global Rx Medical Food Market, By Product Type:
o Pills
o Powder
o Liquid
o Others (wafers, chewables, bars)
• Global Rx Medical Food Market, By Therapeutic Application:
o Pain Management
o Sleep Disorder
o Neurological Disorder
o GI Disorder
o Pulmonary Disorders
o Metabolic Disorders
o Others (fibrosis, dialysis, AIDS, etc.)
• Global Rx Medical Food Market, By Distribution Channel:
o Retail Pharmacies
o Online Pharmacies
• Global Rx Medical Food Market, By Geography:
o North America
By Product Type:
Pills
Powder
Liquid
Others (wafers, chewables, bars)
By Therapeutic Application:
Pain Management
Sleep Disorder
Neurological Disorder
GI Disorder
Pulmonary Disorders
Metabolic Disorders
Others (fibrosis, dialysis, AIDS, etc.)
By Distribution Channel:
Retail Pharmacies
Online Pharmacies
By Country:
U.S.
Canada
o Europe
By Product Type:
Pills
Powder
Liquid
Others (wafers, chewables, bars)
By Therapeutic Application:
Pain Management
Sleep Disorder
Neurological Disorder
GI Disorder
Pulmonary Disorders
Metabolic Disorders
Others (fibrosis, dialysis, AIDS, etc.)
By Distribution Channel:
Retail Pharmacies
Online Pharmacies
By Country:
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
o Asia-Pacific
By Product Type:
Pills
Powder
Liquid
Others (wafers, chewables, bars)
By Therapeutic Application:
Pain Management
Sleep Disorder
Neurological Disorder
GI Disorder
Pulmonary Disorders
Metabolic Disorders
Others (fibrosis, dialysis, AIDS, etc.)
By Distribution Channel:
Retail Pharmacies
Online Pharmacies
By Country:
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Latin America
By Product Type:
Pills
Powder
Liquid
Others (wafers, chewables, bars)
By Therapeutic Application:
Pain Management
Sleep Disorder
Neurological Disorder
GI Disorder
Pulmonary Disorders
Metabolic Disorders
Others (fibrosis, dialysis, AIDS, etc.)
By Distribution Channel:
Retail Pharmacies
Online Pharmacies
By Country:
Brazil
Mexico
Rest of Latin America
o Middle East
By Product Type:
Pills
Powder
Liquid
Others (wafers, chewables, bars)
By Therapeutic Application:
Pain Management
Sleep Disorder
Neurological Disorder
GI Disorder
Pulmonary Disorders
Metabolic Disorders
Others (fibrosis, dialysis, AIDS, etc.)
By Distribution Channel:
Retail Pharmacies
Online Pharmacies
By Country:
GCC
Israel
Rest of Middle East
o Africa
By Product Type:
Pills
Powder
Liquid
Others (wafers, chewables, bars)
By Therapeutic Application:
Pain Management
Sleep Disorder
Neurological Disorder
GI Disorder
Pulmonary Disorders
Metabolic Disorders
Others (fibrosis, dialysis, AIDS, etc.)
By Distribution Channel:
Retail Pharmacies
Online Pharmacies
By Country:
South Africa
Central Africa
North Africa
• Company Profiles
o Abbott Laboratories *
Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments
o Danone
o Mead Johnson & Company, LLC.
o Fresenius Kabi AG
o Nestle
o Primus Pharmaceuticals, Inc.
o Targeted Medical Pharma
o Pivotal Therapeutics
o Enzymotec Ltd.
o AlfaSigma
"*" marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objective and assumption
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
? Market Definition and Scope
o Executive Summary
? Market Snippet By Product Type
? Market Snippet By Therapeutic Application
? Market Snippet By Distribution Channel
? Market Snippet By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
? Drivers
? Restraints
? Market Opportunities
o PEST Analysis
o Impact Analysis
4. Global Rx Medical Food Market, By Product Type, 2017 - 2025 (US$ Mn)
o Introduction
? Market Share Analysis, 2016 and 2025 (%)
? Y-o-Y Growth Analysis, 2017 - 2025
? Segment Trends
o Pills
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
o Powder
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
o Liquid
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
o Others (Wafers, Chewables, Bars)
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
5. Global Rx Medical Food Market, By Therapeutic Application , 2017 - 2025 (US$ Mn)
o Introduction
? Market Share Analysis, 2016 and 2025 (%)
? Y-o-Y Growth Analysis, 2017 - 2025
? Segment Trends
o Pain Management
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
o Sleep Disorder
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
o Neurological Disorder
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
o GI Disorder
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
o Pulmonary Disorder
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
o Metabolic Disorder
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
o Others (fibrosis, dialysis, AIDS, etc.)
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
6. Global Rx Medical Food Market, By Distribution Channel, 2017 - 2025 (US$ Mn)
o Introduction
? Market Share Analysis, 2016 and 2025 (%)
? Y-o-Y Growth Analysis, 2017 - 2025
? Segment Trends
o Retail Pharmacies
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
o Online Pharmacies
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
7. Global Rx Medical Food Market, By Regions, 2017 - 2025 (US$ Mn)
o Introduction
? Market Share Analysis, By Region, 2016 and 2025 (%)
? Y-o-Y Growth Analysis, For Regions, 2017 - 2025
o North America
? Market Size and Forecast, By Product Type, 2017 - 2025 (US$ Mn)
? Market Size and Forecast, By Therapeutic Application, 2017 - 2025 (US$ Mn)
? Market Size and Forecast, By Distribution Channel, 2017 - 2025 (US$ Mn)
? Market Size and Forecast, By Country, 2017 - 2025 (US$ Mn)
? U.S.
? Canada
o Europe
? Market Size and Forecast, By Product Type, 2017 - 2025 (US$ Mn)
? Market Size and Forecast, By Therapeutic Application, 2017 - 2025 (US$ Mn)
? Market Size and Forecast, By Distribution Channel, 2017 - 2025 (US$ Mn)
? Market Size and Forecast, By Country, 2017 - 2025 (US$ Mn)
? Germany
? U.K.
? France
? Italy
? Spain
? Russia
? Rest of Europe
o Asia Pacific
? Market Size and Forecast, By Product Type, 2017 - 2025 (US$ Mn)
? Market Size and Forecast, By Therapeutic Application, 2017 - 2025 (US$ Mn)
? Market Size and Forecast, By Distribution Channel, 2017 - 2025 (US$ Mn)
? Market Size and Forecast, By Country, 2017 - 2025 (US$ Mn)
? China
? India
? Japan
? Australia
? South Korea
? ASEAN
? Rest of APAC
o Latin America
? Market Size and Forecast, By Product Type, 2017 - 2025 (US$ Mn)
? Market Size and Forecast, By Therapeutic Application, 2017 - 2025 (US$ Mn)
? Market Size and Forecast, By Distribution Channel, 2017 - 2025 (US$ Mn)
? Market Size and Forecast, By Country, 2017 - 2025 (US$ Mn)
? Brazil
? Mexico
? Rest of Latin America
o Africa
? Market Size and Forecast, By Product Type, 2017 - 2025 (US$ Mn)
? Market Size and Forecast, By Therapeutic Application, 2017 - 2025 (US$ Mn)
? Market Size and Forecast, By Distribution Channel, 2017 - 2025 (US$ Mn)
? Market Size and Forecast, By Country, 2017 - 2025 (US$ Mn)
? South Africa
? Central Africa
? North Africa
o Middle East
? Market Size and Forecast, By Product Type, 2017 - 2025 (US$ Mn)
? Market Size and Forecast, By Therapeutic Application, 2017 - 2025 (US$ Mn)
? Market Size and Forecast, By Distribution Channel, 2017 - 2025 (US$ Mn)
? Market Size and Forecast, By Country, 2017 - 2025 (US$ Mn)
? GCC
? Israel
? Rest of Middle East
8. Competitive Landscape
o Heat Map Analysis
o Company Profiles
? Abbott Laboratories*
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Developments/Updates
? Danone
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Developments/Updates
? Mead Johnson & Company, LLC.
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Developments/Updates
? Fresenius Kabi AG
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Developments/Updates
? Nestle
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Developments/Updates
? Primus Pharmaceuticals, Inc.
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Developments/Updates
? Targeted Medical Pharma
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Developments/Updates
? Pivotal Therapeutics
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Developments/Updates
? Enzymotec Ltd.
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Developments/Updates
? AlfaSigma
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Developments/Updates
9. Section
o References
o Research Methodology
o About us and Sales Contact
*Browse 40 market data tables and 35 figures on "Rx Medical Food Market - Global forecast to 2025".